The stock trades at a forward price-to-earnings multiple of 5.2x with roughly 33% headroom to the analyst consensus target and has beaten or matched estimates in all four of the last four reported quarters, but quality sits well below the minimum threshold — a Piotroski score of 3 out of 9, no competitive moat — revenue is contracting 4% year over year, a confirmed death-cross technical pattern has triggered a hard block, and 18% short interest signals that the market views the depressed multiple as earned rather than as a value opportunity.
Thesis pillars
- Death Cross Falling Knife Downtrend→Stable
- Deep Discount Offset By Justified Short Interest↑Improving
- Quality Floor Breach Weak Fundamentals→Stable
- +1 more pillar — see the Why tab for full reasoning
FMC Corporation (FMC) Stock Analysis
Falling Knife setup · Inst Constrain edge
Basic Materials · Agricultural Inputs
Sell if holding. Engine safety override at $10.07: Quality below floor (1.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.3/10 and A.R:R 3.0:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 29%; Below-average business quality; Negative price momentum.
FMC Corporation develops, markets, and sells crop protection chemicals — insecticides, herbicides, fungicides — plus biologicals and plant health products in a single global segment, employing approximately 5,500 people across four regions. Revenue comes from proprietary active... Read more
Sell if holding. Engine safety override at $10.07: Quality below floor (1.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.3/10 and A.R:R 3.0:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 29%; Below-average business quality; Negative price momentum. Chart setup: Death cross, below all MAs, RSI 38, MACD bearish. Score 4.3/10, moderate confidence.
Passes 5/8 gates (favorable risk/reward ratio, clean insider activity, earnings proximity 90d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: speculative.
Recent developments
updated 2026-07-30Recent Developments — FMC Corporation
Latest news
- NEWS FMC Sees Q4 Adj EPS $1.09-$1.33 vs $1.01 Est; Sees Sales $1.060B-$1.200B vs $1.095B Est — benzinga Jul 29, 2026 negative
- NEWS FMC Sees Q3 Adj EPS $0.05-$0.13 vs $0.63 Est; Sees Sales $840.000M-$900.000M vs $950.329M Est — benzinga Jul 29, 2026 negative
- NEWS FMC Q2 Adj. EPS $0.26 Beats $0.22 Estimate, Sales $867.000M Miss $905.171M Estimate — benzinga Jul 29, 2026 positive
- NEWS FMC Lowers FY2026 Adj EPS Guidance from $1.63-$1.89 to $1.19-$1.49 vs $1.69 Est; Lowers FY2026 Sales Guidance from $3.60 — benzinga Jul 29, 2026 negative
- NEWS Barclays Maintains Underweight on FMC, Lowers Price Target to $11 — benzinga Jul 27, 2026 negative
Generated 2026-07-30T22:23:47Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMProductRynaxypyr® active10-K Item 1: 'Rynaxypyr® active (chlorantraniliprole), the world's leading insect control technology – with annual revenues of approximately $0.8 billion in 2025'
- LOWProductCyazypyr® active10-K Item 1: 'Cyazypyr® active (cyantraniliprole), which supports a portfolio of products that generated revenues of approximately $0.4 billion in 2025'
- MEDIUMSupplierChina and India intermediates10-K Item 1A: 'We source critical intermediates and finished products from a number of suppliers, largely outside of the U.S. and principally in China and India'
Material Events(8-K, last 90d)
- 2026-04-29Item 5.02LOWBoard director Dirk A. Kempthorne, a member of the FMC board since 2009, passed away. No successor named. The 2026 Incentive Stock Plan was separately approved at the April 28, 2026 Annual Meeting, replacing the 2023 plan.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
4 floor-breakers
Revenue shrinking — -4.1% YoY. Growth thesis broken unless recovery story develops.static
Cyclical trough — margins compressed or negative. Profitability typically recovers with the cycle, but floor fires on current data.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $10.07: Quality below floor (1.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.3/10 and A.R:R 3.0:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 29%; Below-average business quality; Negative price momentum. Chart setup: Death cross, below all MAs, RSI 38, MACD bearish. Prior stop was $9.65. Score 4.3/10, moderate confidence.
Take-profit target: $13.35 (+33.4% upside). Prior stop was $9.65. Stop-loss: $9.65.
Quality below floor (1.7 < 4.0).
FMC Corporation trades at a P/E of N/A (forward 5.0). TrendMatrix value score: 7.2/10. Verdict: Sell.
22 analysts cover FMC with a consensus score of 3.4/5. Average price target: $15.
What does FMC Corporation do?FMC Corporation develops, markets, and sells crop protection chemicals — insecticides, herbicides, fungicides — plus...
FMC Corporation develops, markets, and sells crop protection chemicals — insecticides, herbicides, fungicides — plus biologicals and plant health products in a single global segment, employing approximately 5,500 people across four regions. Revenue comes from proprietary active ingredients; Rynaxypyr® active generated approximately $0.8 billion in 2025, with Cyazypyr® active brands at approximately $0.4 billion. In February 2026, the Board authorized a strategic review including potential sale of the company.